SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Trading Update

15 Jul 2019 07:00

RNS Number : 4376F
The Mission Marketing Group PLC
15 July 2019
 

 

 

 

The Mission Marketing Group plc 

 

Trading update and notice of interim results

  

The Mission Marketing Group plc ("themission", "the Company" or "the Group", AIM: TMMG), the technology-embraced marketing communications and advertising group, today issues a trading update for the six months ended 30 June 2019.

 

The Board is pleased to report that the Group expects to report results for the first half of the year in line with its KPI targets of revenue growth of 5% and profit* growth of 10% from continuing operations**, continuing the Group's track record of growth over the past eight years.

 

The Group made no new acquisitions in the period but settled £3.1m of obligations in relation to acquisitions made in prior years. The Group's net bank debt at 30 June 2019 was £5.2m (30 June 2018: £7.8m) and the Group's debt leverage ratio (the ratio of net bank debt to EBITDA) reduced further, to x0.5 on a comparable, pre-IFRS 16, basis (30 June 2018: x0.7) and to x0.9 on an IFRS 16 basis (30 June 2018: x1.3).

 

As in previous years, the Board expect the Group's results for the year to 31 December 2019 to again have a significant bias towards the second half.

 

The Board intends to announce the Group's interim results on 25 September 2019.

 

* Headline profit before tax, calculated excluding the profit/loss on investments, acquisition-related items and start-up losses

** Continuing operations exclude the results from BroadCare, sold on 12 November 2018

 

Impact of the adoption of IFRS 16: Leases

The Group has implemented IFRS 16: Leases using the full retrospective approach with effect from 1 January 2018. The impact of the new accounting standard is that assets and liabilities as at the transition date of 1 January 2018 will increase by approximately £8m for assets previously accounted for as operating leases. The impact on profit before taxation is insignificant but approximately £2.6m of operating lease expenses will be reclassified as depreciation and interest charges in the full year, and £1.3m in each of the six month periods ended 30 June 2018 and 2019. Accordingly, EBITDA will increase by a corresponding amount.

 

Enquiries:

David Morgan, Chairman

James Clifton, Chief Executive

Peter Fitzwilliam, Finance Director

The Mission Marketing Group plc

 

 

020 7462 1415

 

 

Mark Percy / James Thomas (Corporate Advisory)

 

Shore Capital (Nomad and Broker)

020 7408 4090

 

themission is a network of entrepreneurial marketing communications Agencies employing over 1,000 people in the UK, Asia and US, working together to provide Clients with the expertise and resource to make them more successful in today's dynamic environment.

 

www.themission.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUUOVRKSABAAR
Date   Source Headline
5th Jun 201912:03 pmRNSEBT Share Dealings
4th Jun 20197:00 amRNSGrowth Share Scheme
20th May 20195:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20192:36 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:53 amRNSDirector/PDMR Shareholding
9th Apr 20197:01 amRNSIssue of Equity
9th Apr 20197:00 amRNSFinal Results & Board Changes
22nd Jan 20197:00 amRNSTrading update and Notice of results
5th Dec 20181:43 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:25 pmRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDisposal
19th Sep 20187:00 amRNSHalf-year Report
26th Jul 20187:00 amRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading update and notice of interim results
10th Jul 20187:00 amRNSBoard changes
19th Jun 20182:33 pmRNSResult of AGM
22nd May 20182:11 pmRNSEBT Share Dealings
22nd May 20182:11 pmRNSHolding(s) in Company
9th May 20182:51 pmRNSDirector/PDMR Shareholding
19th Apr 20187:00 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSAcquisition of Krow Communications
10th Apr 20187:00 amRNSFinal Results
25th Jan 20187:00 amRNSTrading Statement
6th Dec 201710:15 amRNSDirector/PDMR Shareholding
31st Oct 20171:41 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSHolding(s) in Company
16th Oct 20173:33 pmRNSDirector/PDMR Shareholding
6th Oct 20172:47 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSHalf-year Report
4th Sep 20177:00 amRNSChange of Adviser
1st Aug 20177:00 amRNSLTIP Options
27th Jul 201710:11 amRNSLTIP Options
24th Jul 20177:00 amRNSTrading Update and Notice of Results
19th Jun 20172:01 pmRNSResult of AGM
27th Apr 20177:40 amRNSAcquisition of RJW & Partners
23rd Mar 20177:00 amRNSAudited results for the year to 31 December 2016
6th Mar 20177:00 amRNSBoard Changes
22nd Feb 20177:00 amRNSGrowth Share Scheme
19th Jan 20177:00 amRNSTrading Update, Growth Shares & Notice of Results
12th Dec 20167:00 amRNSDirectors Dealing
25th Nov 20167:00 amRNSDirector Dealing
18th Nov 20167:00 amRNSReceipt of Industry Awards
12th Oct 20163:30 pmRNSDirector/PDMR Shareholding
10th Oct 20167:00 amRNSLaunch of new Sales Promotion business
22nd Sep 20167:00 amRNSHalf-year Report
21st Jul 20167:00 amRNSTrading update and notice of results
14th Jun 20162:58 pmRNSResult of AGM
17th May 20163:56 pmRNSLTIP Awards
31st Mar 20163:34 pmRNSIssue of deferred consideration shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.